Find your path to Michael
1,147 people in our graph share verified history with Michael — schools, employers, funds. One of them is your warm intro.
Kyle DohertyunlockedMichael: together at Morgan Stanley (2005–2006)
×5Michael: together at Morgan Stanley
×3Michael: together at Cornell
Michael: together at Regeneron Pharmaceuticals
Experience
- Regeneron VenturesGeneral Partnercurrent2024 — present
- XenImmune Therapeutics, Inc.Board Membercurrent2021 — presentNew York, United States
- Excision BioTherapeuticsBusiness Advisor2020 — 2024New York, United States
- Rover DiagnosticsBoard Member2020 — 2024New York, United States
- Unnatural ProductsBoard Member2020 — 2024New York, United States
- ImmunaiSeniorAdvisor2020 — 2022New York, United States
- Quentis Therapeutics, IncPresident and CEO2017 — 2019New York City Metropolitan Area
- Regeneron PharmaceuticalsSenior Vice President, Strategy and Investor Relations2010 — 2017
- Credit SuisseBiotech Analyst2006 — 2010
- Morgan StanleyBiotech Analyst2004 — 2006
- AntigenicsSenior Director, Business Development2002 — 2004
- New York Presbyterian HospitalResident1997 — 2000New York City Metropolitan Area
Deals · 1
Tasca TherapeuticsBoard seat
via SOSV · filed Dec 2025 · $70.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at SOSV
Frequently asked questions
- Who is Michael Aberman?
- Partner at SOSV
- Where does Michael Aberman work?
- Michael Aberman is Partner at SOSV.
- What check size does Michael Aberman write?
- Michael Aberman typically writes checks of $100K – $2M.
- What boards does Michael Aberman sit on?
- Michael Aberman holds tracked board seats at Tasca Therapeutics.
- Where did Michael Aberman go to school?
- Michael Aberman studied at The Wharton School (MBA, Healthcare); University of Toronto (MD, Medicine); Cornell University (BA, Biology).
Same school
Also attended The Wharton School2,000
Fred WilsonCo-founder & Partner at Union Square VenturesSarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalJack AbrahamFounder, CEO & Managing Partner of Atomic
+ 1,994 more
Also attended University of Toronto595
Ilya SutskeverCo-founder of OpenAI; co-founder & CEO of Safe SuperintelligenceNick FrosstCo-founder of CohereYasmin RazaviInvestor at Spark CapitalImran BashirFounding Partner, Chief Operating Officer at Extreme Venture PartnersKarim GillaniGeneral Partner at Luge CapitalAndrew MiklasGeneral Partner at Y Combinator
+ 589 more
Also attended Cornell University1,171
Jenny LeeSenior Managing Partner at Granite AsiaNeeraj AgrawalGeneral Partner at Battery VenturesJohn ZimmerCo-founder of LyftMichelle FernandesInvestor at Index VenturesMike ZakInvestor at CRV (Charles River Ventures)Micah RosenbloomGeneral Partner at Founder Collective
+ 1,165 more
Shared employers
Also worked at Excision BioTherapeutics7
Yuki ShiratoSenior Advisor at Pangaea Ventures Us Inc.Benjamin LimDeputy Director at SGInnovateAriane TomManaging Director at Kaleida CapitalAshok KrishnamurthiManaging Partner at GreatPoint VenturesJenny YipManaging Partner at Adjuvant CapitalMarcelo DelgadoInvestor at Borderless Venture
+ 1 more
Also worked at Unnatural Products6
Also worked at Regeneron Pharmaceuticals19
David SchenkeinInvestor at GV (Google Ventures)Justin LiuVice President at Sapphire VenturesLisa PurcellInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesRick DeweyEntrepreneur-in-Residence at Versant VenturesMax KanevskyVenture Partner at Excelerate Health Ventures
+ 13 more
Also worked at Credit Suisse1,019
Bill GurleyGeneral Partner Emeritus at BenchmarkMike SpeiserManaging Director at Sutter Hill VenturesNik StoronskyCo-founder & CEO of RevolutVlad YatsenkoCo-founder & CTO of RevolutRyan IsonoDeal Partner at Felicis VenturesAryo TehranianManaging Director at Mayfair Equity Partners
+ 1,013 more